Management plans to file for regulatory approval of "Tresmi" for PAH and ILD this year, with commercial launch targeted for next year. Tyvaso DPI platform enhancement -- Introduction of 80-microgram ...
Editor’s note: The Union-Tribune’s Eddie Brown is breaking down prospects, position by position, leading up to the NFL draft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results